FMC (Fresenius Medical Care) closes Renal Care Group buy:
This article was originally published in Clinica
Fresenius Medical Care (FMC) has completed the acquisition of US dialysis services provider Renal Care Group after the transaction received approval from the US Federal Trade Commission. Bad Homburg, Germany-based FMC agreed to sell around 100 dialysis clinics to National Renal Institutes in February to alleviate antitrust concerns.
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.